Evaluation of novel 111In-labeled gonadotropin-releasing hormone peptides for human prostate cancer imaging |
| |
Authors: | Jingli Xu Changjian Feng Yubin Miao |
| |
Institution: | 1. Department of Radiology, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA;2. College of Pharmacy, University of New Mexico, Albuquerque, NM 87131, USA |
| |
Abstract: | The purpose of this study was to evaluate the tumor targeting and imaging properties of novel 111In-labeled gonadotropin-releasing hormone (GnRH) peptides for human prostate cancer. Three new 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-linker-d-Phe-(d-Lys6-GnRH) peptides with different hydrocarbon linkers were designed to evaluate their effects on GnRH receptor binding affinities. The Aoc (aminooctanoic acid) linker was better than βAla (3-aminopropanoic acid) and Aun (aminoundecanoic acid) linkers in retaining strong receptor binding affinity. DOTA-Aoc-d-Phe-(d-Lys6-GnRH) exhibited 6.6 ± 0.1 nM GnRH receptor binding affinity. 111In-DOTA-Aoc-d-Phe-(d-Lys6-GnRH) exhibited fast tumor uptake and urinary clearance in DU145 human prostate cancer-xenografted nude mice. The DU145 tumor lesions could be clearly visualized by single photon emission computed tomography (SPECT)/CT using 111In-DOTA-Aoc-d-Phe-(d-Lys6-GnRH) as an imaging probe, providing an insight into the design of new GnRH peptides for prostate cancer in the future. |
| |
Keywords: | Prostate cancer Single photon emission computed tomography |
本文献已被 ScienceDirect 等数据库收录! |
|